Products for Research Use Only
RegisterLogin

Retifanlimab

CAT: 0804-HY-P99941-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99941-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb) . Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA) [1].
CAS Number
2079108-44-2
Product Name Alternative
INCMGA-00012; MGA-012
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/retifanlimab.html
Purity
96.84
Solubility
10 mM in DMSO
Smiles
[Retifanlimab]
Molecular Weight
(145.35 kDa)
References & Citations
[1]D V T Catenacci, et al. Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A. ESMO Open. 2022 Oct;7 (5) :100563.|[2]Shaukat A, et al. Retifanlimab: a breakthrough for the management of Merkel cell carcinoma[J]. IJS Oncology, 2023, 8 (3) : 18-20.|[3]La Motte-Mohs R, et al. Preclinical characterization of MGD013, a PD-1 x LAG-3 bispecific DART® molecule[J]. Lung, 2017, 28 (10/18) : 56.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
MBS5819101Retifanlimab
GTR18338035-01Retifanlimab Antibody
DHH02218Research Grade Retifanlimab
KBI1590KRIBIOLISA™ Retifanlimab ELISA
E55B0463Retifanlimab (Reference antibody)
ICH5296-10mgRetifanlimab Biosimilar - Research Grade
GTR18697736-01Retifanlimab Human Monoclonal Antibody
A138536Retifanlimab Biosimilar (Monoclonal, IgG4)
GTR18780338-01(Retifanlimab) Biosimilar Reference Antibody
592153Retifanlimab (PDCD1, PD1, CD279)

Popular Products